Sun Pharma fourth quarter profit almost doubles but misses estimates
Net profit for the world`s fifth-largest generic drugs maker in the January-March quarter jumped to 17.1 billion rupees ($255 million) from 8.9 billion rupees in the same period a year earlier. But that was below a Thomson Reuters StarMine SmartEstimate of 19.14 billion rupees.
New Delhi: Union Minister for Health and Family Welfare JP Nadda witness the signing ceremony of PPP agreement between ICMR and Sun Pharma, in Research and Innovation in Preventive Health, in New Delhi on April 25, 2016. (Photo: IANS)